Heat shock protein 27 delays Ca2+-induced cell death in a caspase-dependent and -independent manner in rat retinal ganglion cells

Investigative Ophthalmology and Visual Science

Volumn 46, Issue 3, 2005, Pages 1085-1091

  Whitlock, N Andrew ^a   Lindsey, Kristie ^a   Agarwal, Neeraj ^b   Crosson, Craig E ^a,d   Ma, Jian Xing ^c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CYCLOHEXIMIDE; CYTOCHROME C; HEAT SHOCK PROTEIN 27; ACTIN; CALCIUM; CASP3 PROTEIN, HUMAN; CASP3 PROTEIN, RAT; CASPASE; ELONGATION FACTOR; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; HSPB1 PROTEIN, RAT; NUCLEAR PROTEIN; PEPTIDE ELONGATION FACTOR 1H; SPIN2 PROTEIN, HUMAN; TUMOR PROTEIN;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CELL DEATH; CELL PROTECTION; CELL SURVIVAL; ENZYME ACTIVATION; GENE OVEREXPRESSION; HEART INFARCTION PREVENTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; RAT; RECEPTOR UPREGULATION; RETINA GANGLION CELL; ANIMAL; CELL LINE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; GENETICS; MASS SPECTROMETRY; METABOLISM; PHYSIOLOGY; UPREGULATION;

ACTINS; ANIMALS; CALCIUM; CASPASE 3; CASPASES; CELL LINE, TRANSFORMED; CELL SURVIVAL; CYTOPROTECTION; ENZYME ACTIVATION; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION; HEAT-SHOCK PROTEINS; HSP70 HEAT-SHOCK PROTEINS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; OXIDATIVE STRESS; PEPTIDE ELONGATION FACTORS; RATS; RETINAL GANGLION CELLS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; UP-REGULATION;

EID: 16244378899     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.04-0042     Document Type: Article

References (43)

1. Osborne NN, Ugarte M, Chao M, et al. Neuroprotection in relation to retinal ischemia and relevance to glaucoma. Surv Ophthalmol. 1999;43:S102-S128.
2. Muller A, Pietri S, Villain M, Frejaville C, Bonne C, Culcas M. Free radicals in rabbit retina under ocular hyperpressure and functional consequences. Exp Eye Res. 1997;64:637-643.
3. Olney JW. The toxic effects of glutamate and related compounds in the retina and the brain. Retina. 1982;2:341-359.
4. Sucher NJ, Lipton SA, Dreyer EB. Molecular basis of glutamate toxicity in retinal ganglion cells. Vis Res. 1997;37:3483-3493.
5. Sucher NJ, Wong LA, Lipton SA. Redox modulation of NMDA receptor-mediated Ca2+ flux in mammalian central neurons. Neuroreport. 1990;1:29-32.
6. Crosson CE, Willis JA, Potter DE. Effect of the calcium antagonist, nifedipine, on ischemic retinal dysfunction. J Ocul Pharmacol. 1990;6:293-299.
7. Block F, Schwarz M. Effects of antioxidants on ischemic retinal dysfunction. Exp Eye Res. 1997;64:559-564.
8. Lam TT, Siew E, Chu R, Tso MO. Ameliorative effect of MK-801 on retinal ischemia. J Ocul Pharmacol Ther. 1997;13:129-137.
9. Takahashi K, Lam TT, Edward DP, Buchi ER, Tso MO. Protective effects of flunarizine on ischemic injury in the rat retina. Arch Ophthalmol. 1992;110:862-870.
10. Yoon YH, Marmor MF. Dextromethorphan protects retina against ischemic injury in vivo. Arch Ophthalmol. 1989;107:409-411.
11. Cohen MV, Walsh RS, Goto M, Downey JM. Hypoxia preconditions rabbit myocardium via adenosine and catecholamine release. J Mol Cell Cardiol. 1995;27:1527-1534.
12. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circ. 1986;74:1124-1136.
13. Clavien PA, Yadav S, Sindram D, Bentley RC. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg. 2000;232:155-162.
14. Peralta C, Bartrons R, Riera L, et al. Hepatic preconditioning preserves energy metabolism during sustained ischemia. Am J Physiol. 2000;279:G163-G171.
15. Cochrane J, Williams BT, Banerjee A, et al. Ischemic preconditioning attenuates functional, metabolic, and morphologic injury from ischemic acute renal failure in the rat. Renal Failure. 1999;21: 135-145.
16. Ogawa T, Mimura Y, Hiki N, Kanauchi H, Kaminishi M. Ischaemic preconditioning ameliorates functional disturbance and impaired renal perfusion in rat ischaemia-reperfused kidneys. Clin Exp Pharmacol Physiol. 2000;27:997-1001.
17. Currie RW, Ellison JA, White RF, Feuerstein GZ, Wang X, Barone FC. Benign focal ischemic preconditioning induces neuronal Hsp70 and prolonged astrogliosis with expression of Hsp27. Brain Res. 2000;863:169-181.
18. Dooley P, Corbett D. Competing processes of cell death and recovery of function following ischemic preconditioning. Brain Res. 1998;794:119-126.
19. Roth S, Li B, Rosenbaum PS, et al. Preconditioning provides complete protection against retinal ischemic injury in rats. Invest Ophthalmol Vis Sci. 1998;39:777-785.
20. Lin J, Roth S. Ischemic preconditioning attenuates hypoperfusion after retinal ischemia in rats. Invest Ophthalmol Vis Sci. 1999;40: 2925-2931.
21. Li Y, Roth S, Laser M, Ma JX, Crosson CE. Retinal preconditioning and the induction of heat-shock protein 27. Invest Ophthalmol Vis Sci. 2003;44:1299-1304.
22. Garrido C, Fromentin A, Bonnotte B, et al. Heat shock protein 27 enhances the tumorigenicity of immunogenic rat colon carcinoma cell clones. Cancer Res. 1998;58:5495-5499.
23. Mehlen P, Schulze-Osthoff K, Arrigo AP. Small stress proteins as novel regulators of apoptosis: heat shock protein 27 blocks Fas/APO-1- and staurosporine-induced cell death. J Biol Chem. 1996; 271:16510-16514.
24. Bruey JM, Ducasse C, Bonniaud P, et al. Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat Cell Biol. 2000; 2:645-652.
25. Bruey JM, Paul C, Fromentin A, et al. Differential regulation of HSP27 oligomerization in tumor cells grown in vitro and in vivo. Oncogene. 2000;19:4855-4863.
26. Garrido C, Ottavi P, Fromentin A, et al. HSP27 as a mediator of confluence-dependent resistance to cell death induced by anticancer drugs. Cancer Res. 1997;57:2661-2667.
27. Garrido C, Bruey JM, Fromentin A, Hammann A, Arrigo AP, Solary E. HSP27 inhibits cytochrome c-dependent activation of procaspase-9. FASEB J. 1999;13:2061-2070.
28. Paul C, Manero F, Gonin S, Kretz-Remy C, Virot S, Arrigo AP. Hsp27 as a negative regulator of cytochrome c release. Mol Cell Biol. 2002;22:816-834.
29. Guenal I, Sidoti-de Fraisse C, Gaumer S, Mignotte B. Bcl-2 and Hsp27 act at different levels to suppress programmed cell death. Oncogene. 1997;15:347-360.
30. Parcellier A, Schmitt E, Gurbuxani S, et al. HSP27 is a ubiquitin-binding protein involved in I-kappaBalpha proteasomal degradation. Mol Cell Biol. 2003;23:5790-5802.
31. Krishnamoorthy RR, Agarwal P, Prasanna G, et al. Characterization of a transformed rat retinal ganglion cell line. Mol Brain Res. 2001;86:1-12.
32. Eng JK, McCormack AL, Yates IIIJR. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J Am Soc Mass Spectrom. 1994;5:976-989.
33. Keller A, Nesvizhskii AI, Kolker E, Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem. 2002;74:5383-5392.
34. Kamradt MC, Chen F, Cryns VL. The small heat shock protein alpha B-crystallin negatively regulates cytochrome c- and caspase-8-dependent activation of caspase-3 by inhibiting its autoproteolytic maturation. Biol Chem. 2001;276:16059-16063.
35. Pandey P, Farber R, Nakazawa A, et al. Hsp27 functions as a negative regulator of cytochrome c-dependent activation of procaspase-3. Oncogene. 2000;19:1975-1981.
36. Rashmi R, Santhosh Kumar TR, Karanagaran D. Human colon cancer cells differ in their sensitivity to curcumin-induced apoptosis and heat shock protects them by inhibiting the release of apoptosis-inducing factor and caspases. FEBS Lett. 2003;538:19-24.
37. Lavoie JN, Mickey E, Weber LA, Landry J. Modulation of actin microfilament dynamics and fluid phase pinocytosis by phosphorylation of heat shock protein 21. J Biol Chem. 1993;268:24210-24214.
38. Landry J, Huot J. Regulation of actin dynamics by stress-activated protein kinase 2 (SAPK2)-dependent phosphorylation of heatshock protein of 27 kDa (Hsp27). Biochem Soc Symp. 1999;64:79-89.
39. Kindas-Mugge I, Rieder C, Frohlich I, Micksche M, Trautinger F, Riedler C. Characterization of proteins associated with heat shock protein hsp27 in the squamous cell carcinoma cell line A431 (published correction appears in Cell Biol Int. 2003;27:79). Cell Biol Int. 2002;26:109-116.
40. Ruest LB, Marcotte R, Wang E. Peptide elongation factor eEF1A-2/S1 expression in cultured differentiated myotubes and its protective effect against caspase-3-mediated apoptosis. J Biol Chem. 2002;277:5418-5425.
41. Chen E, Proestou G, Bourbeau D, Wang E. Rapid upregulation of peptide elongation factor EF-1alpha protein levels is an immediate early event during oxidative stress-induced apoptosis. Exp Cell Res. 2000;259:140-148.
42. Talapatra S, Wagner JD, Thompson CB. Elongation factor-1 alpha is a selective regulator of growth factor withdrawal and ER stress-induced apoptosis. Cell Death Differ. 2002;9:856-861.
43. Fletcher BS, Dragstedt C, Notterpek L, Nolan GP. Functional cloning of SPIN-2, a nuclear anti-apoptotic protein with roles in cell cycle progression. Leukemia. 2002;16:1507-1518.